Advanced Biomed regains Nasdaq compliance after reverse stock split; stock remains listed

Advanced Biomed Inc.

Received Panel decision on March 12, 2026 confirming compliance with Minimum Bid Price Rule.
Reverse stock split completed Feb 20, 2026 brought closing bid price to $1.00+.
Company will remain listed on Nasdaq subject to one-year Panel monitor under Rule 5815(d)(4)(A).
Previously appealed delisting determination on Jan 21, 2026; hearing held Feb 17, 2026.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.